ACETAMINOPHEN 500 MG

ACETAMINOPHEN 500 MG was reported 228 times

ACETAMINOPHEN 500 MG is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 MUSCLE RELAXANT DRUG LEVEL ABOVE THERAPEUTIC 1 0.1250
1 BASILAR ARTERY ANEURYSM 1 0.0303
2 MANUFACTURING PRODUCTION ISSUE 1 0.0096
3 EXPLORATORY OPERATION 1 0.0078
4 VERTEBRAL ARTERY STENOSIS 1 0.0065
5 NECROTISING SOFT TISSUE INFECTION 1 0.0043
6 GENITAL BLISTER 1 0.0036
7 BLOOD CREATINE PHOSPHOKINASE DECREASED 1 0.0030
8 CEREBRAL ARTERY STENOSIS 1 0.0020
9 INCORRECT DRUG DOSAGE FORM ADMINISTERED 1 0.0016
10 LABORATORY TEST INTERFERENCE 1 0.0013
11 ARTERIOVENOUS MALFORMATION 1 0.0011
12 BLADDER OPERATION 1 0.0009
13 RECTAL ULCER 1 0.0009
14 ACUTE LUNG INJURY 1 0.0008
15 PHYSICAL PRODUCT LABEL ISSUE 1 0.0008
16 CARDIOVERSION 1 0.0007
17 PRERENAL FAILURE 1 0.0007
18 PHARYNGEAL DISORDER 2 0.0007
19 INTELLECTUAL DISABILITY 1 0.0007
20 BLOOD PRESSURE IMMEASURABLE 1 0.0007
21 MEDICAL DEVICE IMPLANTATION 1 0.0006
22 RECALLED PRODUCT 1 0.0006
23 OCCULT BLOOD POSITIVE 1 0.0005
24 SUDDEN HEARING LOSS 1 0.0005
25 CAPILLARY LEAK SYNDROME 1 0.0005
26 RETROPERITONEAL HAEMATOMA 1 0.0005
27 SINUS OPERATION 1 0.0004
28 OXYGEN SATURATION ABNORMAL 1 0.0004
29 VOMITING PROJECTILE 1 0.0003
30 PRODUCT LABEL CONFUSION 2 0.0003
31 NEGATIVE THOUGHTS 1 0.0003
32 STUPOR 1 0.0003
33 REFUSAL OF TREATMENT BY PATIENT 2 0.0003
34 CHRONIC SINUSITIS 1 0.0003
35 GASTRIC INFECTION 1 0.0003
36 CREATININE RENAL CLEARANCE DECREASED 1 0.0002
37 INTERNATIONAL NORMALISED RATIO DECREASED 1 0.0002
38 LIVER FUNCTION TEST INCREASED 5 0.0002
39 HAEMOLYTIC ANAEMIA 2 0.0002
40 ORGANISING PNEUMONIA 1 0.0002
41 PRODUCT COLOUR ISSUE 1 0.0002
42 SERUM FERRITIN INCREASED 1 0.0002
43 BRUXISM 1 0.0002
44 SOCIAL AVOIDANT BEHAVIOUR 1 0.0002
45 INFUSION RELATED REACTION 11 0.0002
46 OLIGURIA 1 0.0002
47 INFUSION SITE EXTRAVASATION 1 0.0002
48 INFUSION SITE SWELLING 1 0.0002
49 ECCHYMOSIS 1 0.0001
50 DROOLING 1 0.0001
51 MENTAL STATUS CHANGES 4 0.0001
52 BLINDNESS TRANSIENT 1 0.0001
53 BOWEL MOVEMENT IRREGULARITY 1 0.0001
54 HYPOALBUMINAEMIA 1 0.0001
55 TORSADE DE POINTES 1 0.0001
56 ATRIAL FLUTTER 1 0.0001
57 VITAMIN D DECREASED 1 0.0001
58 UNRESPONSIVE TO STIMULI 3 0.0001
59 LOCAL SWELLING 2 0.0001
60 ASPARTATE AMINOTRANSFERASE INCREASED 6 0.0001
61 RECALLED PRODUCT ADMINISTERED 1 0.0001
62 ALANINE AMINOTRANSFERASE INCREASED 6 0.0001
63 VENTRICULAR EXTRASYSTOLES 1 0.0001
64 PRODUCT ODOUR ABNORMAL 1 0.0001
65 MELAENA 2 0.0001
66 TRANSAMINASES INCREASED 2 0.0001
67 STATUS EPILEPTICUS 1 0.0001
68 ACCIDENT 1 0.0001
69 MUSCLE RIGIDITY 1 0.0001
70 TENDON RUPTURE 1 0.0001
71 SECRETION DISCHARGE 1 0.0001
72 INFUSION SITE PAIN 1 0.0001
73 IMMUNE SYSTEM DISORDER 1 0.0001
74 DYSMENORRHOEA 1 0.0001
75 ORAL DISCOMFORT 1 0.0001
76 HYPOMAGNESAEMIA 1 0.0001
77 DEMENTIA 2 0.0001
78 SUBDURAL HAEMATOMA 1 0.0001
79 APATHY 1 0.0001
80 CHILLS 8 0.0001
81 HAEMORRHAGE INTRACRANIAL 1 0.0001
82 DRUG DISPENSING ERROR 1 0.0001
83 PRODUCT USE COMPLAINT 1 0.0001
84 ABSCESS 1 0.0001
85 VENTRICULAR TACHYCARDIA 1 0.0001
86 HYPOXIA 2 0.0001
87 COLD SWEAT 1 0.0001
88 ELECTROCARDIOGRAM QT PROLONGED 2 0.0001
89 BONE DISORDER 1 0.0001
90 POST PROCEDURAL COMPLICATION 1 0.0001
91 EAR PAIN 1 0.0001
92 DEPRESSED LEVEL OF CONSCIOUSNESS 2 0.0001
93 SPINAL FRACTURE 1 0.0000
94 BODY TEMPERATURE INCREASED 1 0.0000
95 INJECTION SITE WARMTH 1 0.0000
96 KNEE ARTHROPLASTY 1 0.0000
97 RECTAL HAEMORRHAGE 2 0.0000
98 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
99 HEPATIC ENZYME INCREASED 3 0.0000
100 SHOCK 1 0.0000
101 THERAPY INTERRUPTED 3 0.0000
102 BLOOD PRESSURE FLUCTUATION 1 0.0000
103 ABASIA 1 0.0000
104 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
105 HYPOPHAGIA 1 0.0000
106 THERAPY CESSATION 2 0.0000
107 RASH GENERALISED 1 0.0000
108 HAEMATOMA 1 0.0000
109 FEAR 1 0.0000
110 DIVERTICULITIS 1 0.0000
111 FEELING COLD 1 0.0000
112 URINARY INCONTINENCE 1 0.0000
113 DRUG-INDUCED LIVER INJURY 1 0.0000
114 HEAD INJURY 1 0.0000
115 BLOOD CREATININE INCREASED 2 0.0000
116 IMPAIRED HEALING 1 0.0000
117 BLOOD PRESSURE DECREASED 2 0.0000
118 VIRAL INFECTION 1 0.0000
119 URINARY RETENTION 1 0.0000
120 HAEMOGLOBIN DECREASED 3 0.0000
121 HEART RATE DECREASED 1 0.0000
122 WRONG TECHNIQUE IN DRUG USAGE PROCESS 1 0.0000
123 CRYING 1 0.0000
124 C-REACTIVE PROTEIN INCREASED 1 0.0000
125 ACCIDENTAL OVERDOSE 1 0.0000
126 RESTLESSNESS 1 0.0000
127 DYSURIA 1 0.0000
128 HEPATIC FUNCTION ABNORMAL 1 0.0000
129 COLITIS 1 0.0000
130 ABNORMAL BEHAVIOUR 1 0.0000
131 TREMOR 4 0.0000
132 RHABDOMYOLYSIS 1 0.0000
133 HYPERHIDROSIS 3 0.0000
134 MUSCULOSKELETAL STIFFNESS 2 0.0000
135 TACHYCARDIA 2 0.0000
136 COLITIS ULCERATIVE 1 0.0000
137 ADVERSE DRUG REACTION 2 0.0000
138 ARRHYTHMIA 1 0.0000
139 COMA 1 0.0000
140 HYPOGLYCAEMIA 1 0.0000
141 LUNG DISORDER 1 0.0000
142 SYNCOPE 2 0.0000
143 FLUSHING 2 0.0000
144 CHEST DISCOMFORT 2 0.0000
145 SINUSITIS 2 0.0000
146 ABDOMINAL PAIN UPPER 4 0.0000
147 SPEECH DISORDER 1 0.0000
148 CONFUSIONAL STATE 3 0.0000
149 OEDEMA 1 0.0000
150 HAEMATOCHEZIA 1 0.0000
151 DIZZINESS 9 0.0000
152 NECK PAIN 1 0.0000
153 BLISTER 1 0.0000
154 OXYGEN SATURATION DECREASED 1 0.0000
155 SURGERY 1 0.0000
156 VOMITING 8 0.0000
157 STOMATITIS 1 0.0000
158 VERTIGO 1 0.0000
159 HYPERSENSITIVITY 3 0.0000
160 LOSS OF CONSCIOUSNESS 2 0.0000
161 DEEP VEIN THROMBOSIS 1 0.0000
162 NAUSEA 12 0.0000
163 INJECTION SITE PRURITUS 1 0.0000
164 PRODUCT QUALITY ISSUE 2 0.0000
165 PAIN 9 0.0000
166 VISION BLURRED 2 0.0000
167 INJECTION SITE REACTION 1 0.0000
168 BURNING SENSATION 1 0.0000
169 DYSPNOEA 8 0.0000
170 CONSTIPATION 3 0.0000
171 BRONCHITIS 1 0.0000
172 DYSGEUSIA 1 0.0000
173 EPISTAXIS 1 0.0000
174 ACUTE KIDNEY INJURY 2 0.0000
175 PRURITUS 5 0.0000
176 BACK PAIN 3 0.0000
177 PARAESTHESIA 2 0.0000
178 INJECTION SITE BRUISING 1 0.0000
179 CARDIAC FAILURE CONGESTIVE 1 0.0000
180 CARDIAC ARREST 1 0.0000
181 GASTROINTESTINAL HAEMORRHAGE 1 0.0000
182 NO ADVERSE EVENT 2 0.0000
183 SUICIDAL IDEATION 1 0.0000
184 CHEST PAIN 2 0.0000
185 COUGH 3 0.0000
186 MIGRAINE 1 0.0000
187 GAIT DISTURBANCE 2 0.0000
188 CONTUSION 1 0.0000
189 ATRIAL FIBRILLATION 1 0.0000
190 HEART RATE INCREASED 1 0.0000
191 HYPERTENSION 2 0.0000
192 WHITE BLOOD CELL COUNT DECREASED 1 0.0000
193 FALL 3 0.0000
194 MUSCULAR WEAKNESS 1 0.0000
195 PYREXIA 3 0.0000
196 SEIZURE 1 0.0000
197 GENERAL PHYSICAL HEALTH DETERIORATION 1 0.0000
198 ABDOMINAL PAIN 2 0.0000
199 PALPITATIONS 1 0.0000
200 OEDEMA PERIPHERAL 1 0.0000
201 INJECTION SITE ERYTHEMA 1 0.0000
202 ASTHENIA 3 0.0000
203 WEIGHT DECREASED 2 0.0000
204 PAIN IN EXTREMITY 2 0.0000
205 BLOOD PRESSURE INCREASED 1 0.0000
206 DRUG INTERACTION 1 0.0000
207 PNEUMONIA 2 0.0000
208 URTICARIA 1 0.0000
209 ABDOMINAL DISCOMFORT 1 0.0000
210 TOXICITY TO VARIOUS AGENTS 1 0.0000
211 URINARY TRACT INFECTION 1 0.0000
212 COVID-19 1 0.0000
213 MUSCLE SPASMS 1 0.0000
214 NASOPHARYNGITIS 1 0.0000
215 BLOOD GLUCOSE INCREASED 1 0.0000
216 HYPOTENSION 1 0.0000
217 HEADACHE 3 0.0000
218 DIARRHOEA 3 0.0000
219 OVERDOSE 1 0.0000
220 RASH 2 0.0000
221 MALAISE 2 0.0000
222 WEIGHT INCREASED 1 0.0000
223 FEELING ABNORMAL 1 0.0000
224 FATIGUE 3 0.0000
225 DRUG INEFFECTIVE 5 0.0000
226 INSOMNIA 1 0.0000
227 INJECTION SITE PAIN 1 0.0000
228 ARTHRALGIA 1 0.0000
229 DEATH 1 0.0000
230 OFF LABEL USE 1 0.0000